Dysbetalipoproteinemia and clomipramine.
Daniel T
DT
Holmes
Phillip
P
Long
Jiri
J
Frohlich
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D053329:Apolipoprotein E2; D001057:Apolipoproteins E / Q000235:genetics; D002997:Clomipramine / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006720:Homozygote; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000139:chemically induced* / Q000235:genetics; D008297:Male; D008875:Middle Aged
D000929:Antidepressive Agents, Tricyclic; D053329:Apolipoprotein E2; D001057:Apolipoproteins E; D002997:Clomipramine